
Acadia Psychiatry provides evidence-based treatment for substance use disorders, including opioid use disorder. Treatment may include medications such as buprenorphine (Suboxone®), along with psychiatric medication management, education, supportive psychotherapy, and individualized care focused on long-term recovery.
MAT/MOUD is an evidence-based treatment for opioid use disorder, and medications such as buprenorphine and methadone are associated with significant reductions in opioid use and improved treatment retention.
Research shows that treatment with buprenorphine or methadone reduces the risk of opioid-related and all-cause mortality, making MOUD an important component of overdose prevention.
Opioid use disorder is a treatable chronic medical condition, and ongoing MOUD can help reduce cravings and withdrawal symptoms while supporting stability, recovery, and improved quality of life.
Copyright © 2026 Acadia Psychiatry, PLLC - All Rights Reserved.